Clinical relevance of chromosome abnormalities in non-small cell lung cancer

Cancer Genetics and Cytogenetics

Volumn 102, Issue 1, 1998, Pages 25-31

  Feder, Madelyn ^a   Siegfried, Jill M ^b   Balshem, Andrew ^a   Litwin, Samuel ^a   Keller, Steven M ^a   Liu, Zemin ^a   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ABERRATION; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; KARYOTYPING; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING;

EID: 0032054912     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00274-4     Document Type: Article

References (41)

1. Parker SL, Tong T, Bolden S, Wingo PA (1996): Cancer statistics, 1996. CA - Cancer J Clinicians 46:5-27.
2. Ettinger DS (1996): NCCN non-small-cell lung cancer practice guidelines. Oncology 10:81-111.
3. McDowell EM, McLaughlin JS, Merenyi DK, Kieffer RF, Harris CC, Trump BF (1978): The respiratory epithelium. V. Histogenesis of lung carcinomas in the human. J Natl Cancer Inst 61:587-606.
4. Mitelman F (1991): Catalog of Chromosome Aberrations in Cancer, 4th ed. Alan R. Liss, Inc., New York.
5. Testa JR, Liu Z, Feder M, Bell DW, Balsara B, Cheng JQ, Taguchi T (in press): Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet.
6. Johansson M, Dietrich C, Mandahl N, Hambraeus G, Johansson L, Clausen PP, Mitelman F, Heim S (1994): Karyotypic characterization of bronchial large cell carcinomas. Int J Cancer 57:463-467.
7. Johansson M, Karauzum SB, Dietrich C, Mandahl N, Hambraeus G, Johansson L, Clausen PP, Mitelman F, Heim S (1994): Karyotypic abnormalities in adenocarcinomas of the lung. Int J Oncol 5:17-26.
8. Johansson M, Jin Y, Mandahl N, Hambraeus G, Johansson L, Mitelman F, Heim S (1995): Cytogenetic analysis of shortterm cultured squamous cell carcinomas of the lung. Cancer Genet Cytogenet 81:46-55.
9. Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou JY, Taguchi T, Keller SM (1994): Cytogenetic analysis of 63 non-small cell lung carcinomas: Recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosom Cancer 11:178-194.
10. Lukeis R, Irving L, Garson M, Hasthorpe S (1990): Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities. Genes Chromosom Cancer 2:116-124.
11. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia. Elsevier, New York.
12. Le Beau MM (1991): Cytogenetic analysis of hematological malignant diseases. In: The ACT Cytogenetics Laboratory Manual, 2nd Edition. MJ Barch, ed. Raven Press, Ltd., New York, pp. 395-445.
13. Bloomfield CD, Goldman A, Hossfeld D, de la Chapelle A (1984): Clinical significance of chromosomal abnormalities in acute nonlymphocytic leukemia. The Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 11:332-350.
14. Arthur DC, Berger R, Golomb HM, Swansbury GJ, Reeves BR, Alimena G, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald GW, Garson OM, Hagemeijer A, Kaneko Y, Mitelman F, Pierre RV, Ruutu T, Sakurai M, Lawler SD, Rowley JD (1989): The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 40:203-216.
15. Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van Den Berghe H, Bloomfield CD, de la Chappelle A, Dewaid G, Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M (1994): Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 73:1-7.
16. Miura I, Siegfried JM, Resau J, Keller SM, Zhou J, Testa JR (1990): Chromosome alterations in 21 non-small cell lung carcinomas. Genes Chromosom Cancer 2:328-338.
17. Siegfried JM (1987): Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors. Cancer Res 47:2903-2910.
18. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
19. Bloomfield CD, Seeker-Walker LM, Goldman AI, Van Den Berghe H, de la Chapelle A, Ruutu T, Alimena G, Garson OM, Golomb HM, Rowley JD, Kaneko Y, Whang-Peng J, Prigogina E, Philip P, Sandberg AA, Lawler SD, Mitelman F (1989): Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 40:171-185.
20. Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, Graziano S, Sorenson GD, Poiesz BJ, Minna J, Linehan M, Zbar B (1987): Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med 317:1109-1113.
21. Kok K, Osinga J, Carritt B, Davis MB, van der Hout AH, van der Veen AY, Landsvater RM, de Leij LFMH, Berendsen HH, Postmus PE, Poppema S, Buys CHCM (1987): Deletion of a DNA sequence at the chromosomal region 3p21 in all types of lung cancer. Nature 330:578-581.
22. Thiberville L, Bourguigon J, Metayer J, Bost F, Diarra-Mehrpour M, Bignon J, Lam S, Martin JP, Nouvet G (1995): Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer. Int J Cancer 64:371-377.
23. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD (1989): p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491-494.
24. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989): Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708.
25. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. (1992): A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
26. Caron de Fromentel C, Soussi T (1992): TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosom Cancer 4:1-15.
27. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J (1994): Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 54:5643-5648.
28. Volm M, Drings P, Mattern J, Sonka J, Vogt-Moykopf I, Wayss K (1985): Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer 56:1396-1403.
29. Bunn PA Jr., Carney DN, Gazdar AF, Whang-Peng J, Matthews MJ (1983): Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res 43:5026-5032.
30. Ten Velde GPM, Schutte B, Vermeulen A, Volovics A, Reynders MMJ, Blijham GH (1988): Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small cell lung cancer. Eur J Cancer Clin Oncol 24:455-460.
31. Cibas ES, Melamed MR, Zaman MB, Kimmel M (1989): The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer 63:1552-1556.
32. Carp NZ, Ellison DD, Brophy PF, Watts P, Chang M-C, Keller SM (1992): DNA content in correlation with postsurgical stage in non-small cell lung cancer. Ann Thorac Surg 53:680-683.
33. Schmidt RA, Rusch VW, Piantadosi S (1992): A flow cytometric study of non-small cell lung cancer classified as T1N0. Cancer 69:78-85.
34. Rice TW, Bauer TW, Gephardt GN, Medendorp SV, McLain DA, Kirby TJ (1993): Prognostic significance of flow cytometry in non-small cell lung cancer. J Thorac Cardiovasc Surg 106:210-217.
35. Siegfried JM, Gaither Davis AL, Testa JR, Hunt JD, Keenan RJ, Yousem SA, Ritter PS, Ferson PF, Landreneau RJ (1994): Ability to culture resectable non-small cell lung carcinomas is correlated with recurrence. Ann Thorac Surg 58:662-667.
36. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992): Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
37. Ried T, Knutzen R, Steinbeck R, Blegan H, Schrock E, Heselmeyer K, du Manoir S, Auer G (1996): Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosom Cancer 15:234-245.
38. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T (1996): Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484.
39. Visakorpi T, Kallioniemi A, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola J, Kallioniemi O-P (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
40. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T (1994): Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218.
41. Isola J, Kallioniemi O-P, Chu L, Fuqua S, Hilsenbeck S, Osborne K, Waldman F (1995): Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147:905-911.